Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Mar 06





A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413



The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Mar 06

language: English

Clinical significance of hemodynamic cerebral ischemia on cognitive function in carotid artery stenosis – A prospective study before and after revascularization

Akioka N., Takaiwa A., Kashiwazaki D., Kuwayama N., Endo S., Kuroda S.

Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan


AIM: Carotid stenosis is known to have negative impacts on cognitive function. However, it is still unclear through which mechanisms cognitive function is impaired in patients with carotid stenosis. This study was aimed to clarify the impact of cerebral hemodynamics on cognitive function in carotid stenosis.
METHODS: This prospective study included totally 109 patients with carotid stenosis who underwent carotid endarterectomy (CEA) or carotid artery stenting (CAS). Using N-­isopropyl-­p-­[123I]-­iodoamphetamine SPECT, cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) to acetazolamide were quantitatively measured in all patients before and after CEA/CAS. Based on preoperative data, the patients were categorized into three groups: Type 1 (CBF≥32ml/min/100g, CVR≥10%), Type 2 (CBF≥32ml/min/100g and CVR<10%), and Type 3 (CBF<32ml/min/100g and CVR<10%). White matter lesions were categorized according to Wahlund grading. Cognitive function was evaluated with Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) before and 3 months after CEA/CAS.
RESULTS: Before CEA/CAS, total RBANS score was significant lower than the age-­matched controls, 84 ± 14 in Type 1 group (n=56), 82 ± 12 in Type 2 group (n=43), and 70 ± 12 in Type 3 group (n=10). Especially, Type 3 patients had further lower score than Type 1 (p=0.008) and Type 2 (p=0.039) patients. There were no significant differences in white matter lesions among three groups. Total RBANS scores significantly improved at 3 months after CEA/CAS in all three groups, and the difference among them completely disappeared.
CONCLUSIONS: These findings strongly suggest that carotid stenosis itself impairs cognitive function and compromised hemodynamic ischemia further declines it. CEA/CAS significantly improve cognitive function. The beneficial effects are most notable in patients with reduced CBF/CVR.

top of page

Publication History

Cite this article as

Corresponding author e-mail